Literature DB >> 19712575

Temporal changes of angiopoietins and Tie2 expression in rat lungs after monocrotaline-induced pulmonary hypertension.

Yu Ji Cho1, Jae Yoon Han, Sang Gab Lee, Byeong Tak Jeon, Wan Sung Choi, Young Sil Hwang, Gu Seob Roh, Jong Deog Lee.   

Abstract

Angiogenic factors such as vascular endothelial growth factor (VEGF) are implicated in pulmonary hypertension (PH). However, the pathway of angiogenic factor-mediated pathologic angiogenesis in PH remains unclear. In this study, we evaluated the temporal expression of angiopoietin (Ang) 1, Ang2, and their receptor (Tie2) as well as VEGF, endothelial nitric oxide synthase (eNOS), inducible NOS (iNOS), and heme oxygenase 1 (HO1) in the monocrotaline-induced PH model. Histologic evaluation showed pathologic vascular remodeling in the arteries of lung sections 1 wk after monocrotaline treatment. Protein levels of Ang1, Ang2, eNOS, iNOS, HO1, and VEGF were increased 1 wk after monocrotaline treatment but Tie2 protein levels were decreased 2 wk afterward. These results suggest that Ang2 mediates vascular remodeling in PH by decreasing Tie2 expression. Therefore, the Ang-Tie2 system may play a role in the pathophysiology of PH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19712575      PMCID: PMC2779210     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  40 in total

1.  Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy.

Authors:  P A Thistlethwaite; S H Lee; L L Du; P L Wolf; C Sullivan; S Pradhan; R Deutsch; S W Jamieson
Journal:  J Thorac Cardiovasc Surg       Date:  2001-07       Impact factor: 5.209

2.  Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.

Authors:  Peter Vajkoczy; Mohammad Farhadi; Andreas Gaumann; Regina Heidenreich; Ralf Erber; Andreas Wunder; Jörg C Tonn; Michael D Menger; Georg Breier
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension.

Authors:  Laurence Dewachter; Serge Adnot; Elie Fadel; Marc Humbert; Bernard Maitre; Anne-Marie Barlier-Mur; Gerald Simonneau; Michel Hamon; Robert Naeije; Saadia Eddahibi
Journal:  Am J Respir Crit Care Med       Date:  2006-08-17       Impact factor: 21.405

Review 4.  Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis.

Authors:  Hideo Kimura; Hiroyasu Esumi
Journal:  Acta Biochim Pol       Date:  2003       Impact factor: 2.149

5.  Signaling and functions of angiopoietin-1 in vascular protection.

Authors:  Nicholas P J Brindle; Pipsa Saharinen; Kari Alitalo
Journal:  Circ Res       Date:  2006-04-28       Impact factor: 17.367

6.  Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells.

Authors:  Jozef Dulak; Alicja Józkowicz; Roberta Foresti; Aneta Kasza; Matthias Frick; Ihor Huk; Colin J Green; Otmar Pachinger; Franz Weidinger; Roberto Motterlini
Journal:  Antioxid Redox Signal       Date:  2002-04       Impact factor: 8.401

7.  Pulmonary expression of iNOS and HO-1 protein is upregulated in a rat model of prehepatic portal hypertension.

Authors:  R A Schroeder; C A Ewing; J V Sitzmann; P C Kuo
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

8.  Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF).

Authors:  Richard P Visconti; Charlene D Richardson; Thomas N Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

9.  Heme oxygenase-1 reduces murine monocrotaline-induced pulmonary inflammatory responses and resultant right ventricular overload.

Authors:  Jun Goto; Kazunobu Ishikawa; Keiichi Kawamura; Yasuyuki Watanabe; Hayato Matumoto; Daisuke Sugawara; Yukio Maruyama
Journal:  Antioxid Redox Signal       Date:  2002-08       Impact factor: 8.401

10.  Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo.

Authors:  Ivan B Lobov; Peter C Brooks; Richard A Lang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-05       Impact factor: 11.205

View more
  9 in total

1.  Delineating the angiogenic gene expression profile before pulmonary vascular remodeling in a lamb model of congenital heart disease.

Authors:  Jing Tian; Sohrab Fratz; Yali Hou; Qing Lu; Agnes Görlach; John Hess; Christian Schreiber; Sanjeev A Datar; Peter Oishi; John Nechtman; Robert Podolsky; Jin-Xiong She; Jeffrey R Fineman; Stephen M Black
Journal:  Physiol Genomics       Date:  2010-10-26       Impact factor: 3.107

Review 2.  Emerging role of angiogenesis in adaptive and maladaptive right ventricular remodeling in pulmonary hypertension.

Authors:  Andrea L Frump; Sébastien Bonnet; Vinicio A de Jesus Perez; Tim Lahm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-02       Impact factor: 5.464

3.  Plasma endothelin-1 and vascular endothelial growth factor levels and their relationship to hemodynamics in idiopathic pulmonary fibrosis.

Authors:  Corey E Ventetuolo; Steven M Kawut; David J Lederer
Journal:  Respiration       Date:  2012-08-03       Impact factor: 3.580

4.  The Role of Astrocytes in Metabolism and Neurotoxicity of the Pyrrolizidine Alkaloid Monocrotaline, the Main Toxin of Crotalaria retusa.

Authors:  Bruno Penas Seara Pitanga; Ravena P Nascimento; Victor Diógenes A Silva; Silvia L Costa
Journal:  Front Pharmacol       Date:  2012-08-03       Impact factor: 5.810

5.  Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension.

Authors:  Sebastian Steven; Matthias Oelze; Moritz Brandt; Elisabeth Ullmann; Swenja Kröller-Schön; Tjebo Heeren; Lan P Tran; Steffen Daub; Mobin Dib; Dirk Stalleicken; Philip Wenzel; Thomas Münzel; Andreas Daiber
Journal:  Oxid Med Cell Longev       Date:  2017-02-28       Impact factor: 6.543

6.  Bayesian Inference Associates Rare KDR Variants with Specific Phenotypes in Pulmonary Arterial Hypertension.

Authors:  Emilia M Swietlik; Daniel Greene; Na Zhu; Karyn Megy; Marcella Cogliano; Smitha Rajaram; Divya Pandya; Tobias Tilly; Katie A Lutz; Carrie C L Welch; Michael W Pauciulo; Laura Southgate; Jennifer M Martin; Carmen M Treacy; Christopher J Penkett; Jonathan C Stephens; Harm J Bogaard; Colin Church; Gerry Coghlan; Anna W Coleman; Robin Condliffe; Christina A Eichstaedt; Mélanie Eyries; Henning Gall; Stefano Ghio; Barbara Girerd; Ekkehard Grünig; Simon Holden; Luke Howard; Marc Humbert; David G Kiely; Gabor Kovacs; Jim Lordan; Rajiv D Machado; Robert V Mackenzie Ross; Colm McCabe; Shahin Moledina; David Montani; Horst Olschewski; Joanna Pepke-Zaba; Laura Price; Christopher J Rhodes; Werner Seeger; Florent Soubrier; Jay Suntharalingam; Mark R Toshner; Anton Vonk Noordegraaf; John Wharton; James M Wild; Stephen John Wort; Allan Lawrie; Martin R Wilkins; Richard C Trembath; Yufeng Shen; Wendy K Chung; Andrew J Swift; William C Nichols; Nicholas W Morrell; Stefan Gräf
Journal:  Circ Genom Precis Med       Date:  2020-12-15

7.  Diaphragm atrophy and contractile dysfunction in a murine model of pulmonary hypertension.

Authors:  Bumsoo Ahn; Hyacinth M Empinado; Monsour Al-Rajhi; Andrew R Judge; Leonardo F Ferreira
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

8.  Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

Authors:  Devashis Mukherjee; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-06-30       Impact factor: 8.915

Review 9.  The role of genomics and genetics in pulmonary arterial hypertension.

Authors:  Emilia M Swietlik; Stefan Gräf; Nicholas W Morrell
Journal:  Glob Cardiol Sci Pract       Date:  2020-04-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.